Advicenne SA
PAR:ALDVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Advicenne SA
PAR:ALDVI
|
FR |
|
K
|
Kopin Corp
F:KOC
|
US |
|
CNB Financial Corp
F:44I
|
US |
|
Coastal Financial Corp (EVERETT)
F:1VD
|
US |
|
Maxim Power Corp
TSX:MXG
|
CA |
|
M
|
McKesson Corp
BMV:MCK
|
US |
|
M
|
McKesson Corp
F:MCK
|
US |
|
Maxim Power Corp
F:MP9
|
CA |
Intrinsic Value
Is ALDVI undervalued or overvalued?
See the intrinsic value estimate for Advicenne SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ALDVI looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ALDVI’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Advicenne Does
Advicenne SA is a specialty pharmaceutical company that focuses on rare kidney and metabolic diseases. It develops prescription medicines for conditions such as distal renal tubular acidosis and cystinuria, where patients often need long-term treatment and care from specialist doctors, especially nephrologists and pediatric teams.
- Headquarters
- France FR
- Employees
- 30
- IPO date
- Dec 6, 2017
Earnings Waterfall
Advicenne SA
The intrinsic value for Advicenne SA (ALDVI) under the Base Case is hidden EUR.
Compared with the current market price of 0.632 EUR, the stock appears hidden.